Salivary orosomucoid 1 as a biomarker of hepatitis b associated hepatocellular carcinoma

HIGHLIGHTS

• who: Jiaoxia He from the DepartmentMedical University have published the Article: Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma, in the Journal: Scientific Reports Scientific Reports of October/31,/2021
• what: Salivary ORMI may be a potential biomarker for diagnosis or screening of HCC, and performed much better when combined with salivary AFP.
• how: The 200 saliva samples from the validation cohort were tested for AFP (ELH-AFP-1 Raybiotech Peachtree Corners GA USA) and ORM1 (243675 Abcam UK) using ELISA kits. For classification variables the authors used the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.